Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)	Acute Ischemic Stroke, Arrhythmias, Cardiac, Arterial Occlusive Diseases, Intracranial Atherosclerosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, coronary artery disorder, heart disorder, intracranial arterial disease, intracranial arteriosclerosis, ischemic stroke, myocardial ischemia, nervous system disorder, stroke disorder, vascular disorder	Active, not recruiting	Not stated	2025-07-11		NCT04010955

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Asan Medical Center	114
Chonbuk National University	3
Chonnam National University Hospital	54
Chung-Ang University Hospital	18
Chungnam National University Hospital	34
Dongtan Sacred Heart Hospital	3
Eulji University Hospital	6
Ewha Womans University	6
Keimyung University Dongsan Medical Center	32
Korea University Ansan Hospital	11
Korea University Guro Hospital	29
Kyungpook National University Hospital	19
Myongji Hospital	3
Pusan National University Hospital	19
Samsung Medical Center	207

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Asan Medical Center	Seoul	South Korea	19